Founded in Buffalo, New York, Roswell Park Cancer Institute is dedicated to pioneering multidisciplinary oncology research and providing comprehensive clinical care. The institute's core mission is to understand, prevent, and cure cancer through innovative research and patient-centered treatment. Roswell Park offers a wide range of services including cancer diagnosis, treatment, and supportive care, targeting both local and international patients seeking advanced cancer therapies.
Notable affiliates include leading oncologists and researchers who contribute to groundbreaking studies in cancer treatment. The institute has garnered support from prominent investors and organizations dedicated to advancing medical research. Key achievements include significant contributions to cancer research, development of new treatment protocols, and improving patient outcomes. Roswell Park's impact is evident in its role as a leader in the oncology field, offering hope and improved quality of life for cancer patients worldwide.

MD Anderson Cancer Center
mdanderson.org

Memorial Sloan Kettering Cancer Center
mskcc.org

Fox Chase Cancer Center
foxchase.org

American Cancer Society
cancer.org

The Mark Foundation for Cancer Research

National Foundation for Cancer Research
nfcr.org

MIT Koch Institute for Integrative Cancer Research
ki.mit.edu

Break Through Cancer

Feinstein Institute for Medical Research

Penn Medicine
pennmedicine.org

Cleveland Clinic

Leukemia & Lymphoma Society
lls.org

Kaleida Health
Organizations similar to Roswell Park Cancer Institute include MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Fox Chase Cancer Center and American Cancer Society.
Roswell Park Cancer Institute was founded in 1898.
Roswell Park Cancer Institute's headquarters is located in Buffalo, NY, US.
Roswell Park Cancer Institute's most recent funding round was for $22M (USD) in November 2019.
As of Nov 19, 2019, Roswell Park Cancer Institute has raised a total of $88.8M (USD).
Roswell Park Cancer Institute has 3,000 employees as of Feb 4, 2024.